Crow's Feet Market Report 2026

The crow's feet market size has grown strongly in recent years. It will grow from $4.29 billion in 2025 to $4.63 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to aging population growth, increased cosmetic awareness, availability of topical anti-aging products, celebrity influence, expansion of aesthetic medicine.

The crow's feet market size is expected to see strong growth in the next few years. It will grow to $6.18 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to advancements in injectable aesthetics, rising male skincare adoption, growth of personalized skincare, increasing disposable income, demand for minimally invasive treatments. Major trends in the forecast period include rising demand for non-invasive anti-aging treatments, increased use of botulinum toxin procedures, growth of at-home skincare solutions, expansion of dermatology and aesthetic clinics, focus on preventive skin aging care.

The increasing consumer preference for non-invasive procedures is expected to drive the growth of the crow’s feet market in the coming years. Non-invasive procedures are aesthetic treatments that enhance skin appearance without requiring surgery or extended recovery periods. The adoption of these procedures is rising due to factors such as demand for quick and effective solutions, technological advancements, minimal downtime, lower risk compared to surgical options, cost effectiveness, and greater awareness of aesthetic care. Non-invasive treatments including botulinum toxin injections, laser resurfacing, microneedling, radiofrequency therapy, chemical peels, and LED light treatments help reduce crow’s feet by relaxing facial muscles, stimulating collagen production, improving skin texture, and enhancing elasticity without surgical intervention. For instance, in June 2024, according to the International Society of Aesthetic Plastic Surgery (ISAPS), a Switzerland-based professional society, 7,887,955 botulinum toxin procedures were performed worldwide in 2024, a widely used non-surgical treatment for crow’s feet and other periocular lines, compared with 9,549,245 procedures in 2023. Therefore, the growing preference for non-invasive procedures is contributing to the expansion of the crow’s feet market.

Major companies operating in the crow’s feet market are increasingly focused on developing red and infrared light therapy masks to offer non-invasive, effective, and at-home solutions for reducing fine lines and wrinkles around the eyes. Red and infrared light therapy masks are skincare devices that use specific light wavelengths to penetrate the skin, stimulate collagen production, and reduce wrinkles and other signs of aging. For example, in October 2024, Solawave, a US-based skincare technology company, launched Eye Recovery Pro, a red and infrared light therapy mask. The device is designed to address early signs of aging in the eye area, including fine lines, wrinkles, crow’s feet, puffiness, dark circles, eyelid drooping, and uneven skin tone. It combines red, deep red, near-infrared, and amber light therapies, which work together to deliver visible improvements within a few weeks when used consistently for three minutes, three times per week.

In August 2024, L’Oréal S.A., a France-based cosmetics company, acquired a 10 percent stake in Galderma Group AG from Sunshine SwissCo AG for $1.85 billion. Through this acquisition, L’Oréal and Galderma aim to establish a strategic scientific partnership that combines Galderma’s expertise in dermatological treatments with L’Oréal’s capabilities in skin biology, diagnostic tools, and evaluation methods to drive innovation in the aesthetics and skincare sector. Galderma Group AG is a Switzerland-based dermatology company specializing in treatments for crow’s feet.

Major companies operating in the crow's feet market are Procter & Gamble, Johnson & Johnson, AbbVie Inc., L'Oréal S.A., Sinclair Pharma plc, Ipsen Pharma, Clarins, Merz Pharma GmbH & Co. KGaA., Vichy Laboratoires, Obagi Cosmeceuticals LLC, Isdin, Hugel Inc., Evolus Inc., Revance Therapeutics Inc., Solta Medical Inc., Peter Thomas Roth Labs LLC, Ortho Dermatologics, SkinMedica Inc., Oxygenetix, Algenist, Lumenis Be Ltd., SkinCeuticals, Solawave.

North America was the largest region in the crow's feet market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the crow's feet market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the crow's feet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the crow's feet market by increasing costs of imported botulinum toxin products, dermal fillers, skincare ingredients, and aesthetic devices. Dermatology clinics in North America and Europe are most affected due to reliance on imported injectables, while Asia-Pacific faces higher product costs. These tariffs are raising treatment prices. However, they are also encouraging domestic formulation development and regional aesthetic manufacturing.

The crow's feet market research report is one of a series of new reports that provides crow's feet market statistics, including crow's feet industry global market size, regional shares, competitors with a crow's feet market share, detailed crow's feet market segments, market trends and opportunities, and any further data you may need to thrive in the crow's feet industry. This crow's feet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Crow’s feet are fine lines and wrinkles that form at the outer corners of the eyes and typically become more noticeable with age. They develop as a result of repeated facial movements such as smiling and squinting, along with the natural decline in collagen levels and skin elasticity. Consistent use of anti-aging ingredients such as retinol and hyaluronic acid can help enhance skin texture and gradually reduce the appearance of fine lines.

The primary treatment types for crow’s feet include topical creams, botulinum toxin injections, chemical peels, dermal fillers, and other treatment options. Topical creams are formulations applied directly to the skin to help minimize the appearance of crow’s feet. These treatments are used across various settings such as hospitals and clinics, dermatology centers, and homecare environments, and are distributed through channels including hospital pharmacies, retail pharmacies, and online pharmacies.

The crow’s feet market consists of revenues earned by entities by providing services such as laser resurfacing, micro-needling, radiofrequency therapy, ultrasound skin tightening, platelet-rich plasma (PRP) therapy, facials with anti-aging benefits, and customized dermatological consultations for wrinkle reduction. The market value includes the value of related goods sold by the service provider or included within the service offering. The crow’s feet market also includes sales of anti-aging skincare products, retinol treatments, hyaluronic acid-based moisturizers, collagen-boosting supplements, sunscreen, facial masks, peptide-infused treatments and at-home skincare devices designed to reduce fine lines and wrinkles around the eyes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.